Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference56 articles.
1. New glaucoma medications: latanoprostene bunod, netarsudil, and fixed combination netarsudil-latanoprost;Mehran;Eye Lond Engl,2020
2. Pathophysiology of hypertension in the absence of nitric oxide/cyclic GMP signaling;Thoonen;Curr Hypertens Rep,2013
3. Regulation of intraocular pressure by soluble and membrane guanylate cyclases and their role in glaucoma;Buys;Front Mol Neurosci,2014
4. Alterations of ocular nitric oxide synthase in human glaucoma;Nathanson;Invest Ophthalmol Vis Sci,1995
5. A review of nitric oxide for the treatment of glaucomatous disease;Aliancy;Ophthalmol Ther,2017